Novo Integrated Sciences (NVOS) 10-K 2020 FY Annual report

Exhibit 3.6

ARTICLES OF AMENDMENT

TO THE ARTICLES OF INCORPORATION

OF

Novo Integrated Sciences, Inc.

Novo Integrated Sciences, Inc., a Nevada corporation (the “Corporation”), hereby amends (“Articles of Amendment”) its articles of incorporation, as amended (“Articles”), as follows:

A. Reverse Stock Split. Upon the Effective Time (as defined below) of these Articles of Amendment, each one (1) share of the Corporation’s common stock, par value $0.001 per share (“Common Stock”) issued and outstanding immediately prior to the Effective Time will be and hereby is automatically reclassified and changed (without any further act) into 1/10^th of a validly issued, fully paid and non-assessable share of Common Stock, without increasing or decreasing the par value thereof, provided that no fractional shares shall be issued in respect of any shares of Common Stock, and that, instead of issuing such fractional shares, any fractional shares shall be rounded up to the next higher whole share (a 1 for 10 reverse stock split), with no changes to the number of authorized shares of Common Stock.

B. Authority to Amend. These Articles of Amendment were adopted by the unanimous consent of the Corporation’s Board on November 9, 2020 and duly approved by the Corporation’s shareholders on November 9, 2020 as required by law and the Corporation’s Articles, as modified by the unanimous consent of the Corporation’s Board on November 20, 2020 pursuant to authority granted to the Board by the shareholders of the Corporation, as modified by the unanimous consent of the Corporation’s Board on December 3, 2020 pursuant to authority granted to the Board by the shareholders of the Corporation. The number of votes cast for the Articles of Amendment by the shareholders was sufficient for approval.

D. Effective Time. The foregoing amendments will become effective on the later of (i) the date on which FINRA clears the corporate actions that are the subject of these Articles of Amendment or (ii) January 29, 2021 (“Effective Time”).

IN WITNESS WHEREOF, the undersigned has executed these Articles of Amendment as of December 3, 2020.

Novo Integrated Sciences, Inc.
By:	/s/ Robert Mattacchione
Name:	Robert Mattacchione
Title:	Chief Executive Officer